candesartan has been researched along with Liver Dysfunction in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
| Excerpt | Relevance | Reference |
|---|---|---|
| " No serious or severe adverse events were reported." | 2.69 | Pharmacokinetics and safety of candesartan cilexetil in subjects with normal and impaired liver function. ( Högemann, A; Hoogkamer, JF; Kirch, W; Kleinbloesem, CH; Nokhodian, A; Ouwerkerk, M; Weidekamm, E, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoogkamer, JF | 1 |
| Kleinbloesem, CH | 1 |
| Ouwerkerk, M | 1 |
| Högemann, A | 1 |
| Nokhodian, A | 1 |
| Kirch, W | 1 |
| Weidekamm, E | 1 |
1 trial available for candesartan and Liver Dysfunction
| Article | Year |
|---|---|
Pharmacokinetics and safety of candesartan cilexetil in subjects with normal and impaired liver function.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Female; Humans; L | 1998 |